Position of the Polish Pharmaceutical Sector on the Reform of Pharmaceutical Legislation in the European Union

Position of the Polish Pharmaceutical Sector on the Reform of Pharmaceutical Legislation in the European Union

Discussions among Member States regarding reform of the European Union's pharmaceutical legislation, which aims to guarantee all its citizens access to affordable medicines and development of their production in EU, are coming to an end. This will ensure strategic resilience and autonomy of the Union, economic growth, and stability of healthcare systems in member countries.

Pharma’s AI prospects get nudged into the future with EU’s AI act  - Pharmaceutical Technology

Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.

Why the new regulation of the pharmaceutical market in Ukraine may lead to a shortage of medicines and the development of a shadow market - expert opinion (VIDEO) The reform of the pharmaceutical market may worsen the situation for patients, causing a shortage of medicines, especially imported ones, and the development of a shadow market. The ban on marketing payments has not reduced prices.